National Health Investors (NHI) Revenue (2009 - 2026)

National Health Investors' Revenue history runs 18 years deep, the most recent figure standing at $115.1 million for Q1 2026.

• Quarterly Revenue rose 28.93% year-over-year to $115.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $401.5 million (up 207.72% YoY) and the FY2025 annual result came in at $375.6 million, up 590.23% from the prior year.
• Revenue was $115.1 million for Q1 2026 at National Health Investors, up from $105.8 million in the prior quarter.
• Across five years, Revenue topped out at $254.2 million in Q4 2022 and bottomed at $12.0 million in Q3 2022.
• A 5-year average of $70.3 million and a median of $77.9 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue tumbled 94.91% — and 2025, when it soared 655.61%.
• National Health Investors' Revenue stood at $254.2 million in 2022, then tumbled by 94.91% to $12.9 million in 2023, then rose by 8.16% to $14.0 million in 2024, then surged by 655.61% to $105.8 million in 2025, then grew by 8.79% to $115.1 million in 2026.
• Business Quant data shows NHI's Revenue at $115.1 million in Q1 2026, $105.8 million in Q4 2025, and $89.8 million in Q3 2025.